Stockreport

Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the National Kidney Foundation Spring Clinical Meetings 2025 [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF Data presentations highlight SPARTAN Study results and real-world case studies of FILSPARI across different IgAN patient backgrounds SAN DIEGO, March 31, 2025 BUSINES [Read more]